Other News Releases in Health Care & Hospitals
New Report: Cigarette Tax Increases Would Raise Billions for Cash-Strapped States, While Reducing Smoking and Winning Voter Approval
New Report: $1 Cigarette Tax Increase Would Raise $252.6 Million for Tennessee and Cut Youth Smoking
New Report: $1 Cigarette Tax Increase Would Raise $209.4 Million for South Carolina and Cut Youth Smoking
Other News Releases in New Products & Services
California Micro Devices Presents High Brightness LED Protection Devices at SIL 2010
A New Business With Old Roots - China Bridge to Help Bring Investment to the U.S., Spur Growth for Chinese and U.S. Companies
NBC to Use AT&T Networking Services for Live Transmission of 2010 Vancouver Olympic Winter Games
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services
GeneraMedix Inc. Launches Fosphenytoin Sodium Injection, USP
LIBERTY CORNER, N.J., Aug. 8 /PRNewswire/ -- GeneraMedix Inc. has
launched Fosphenytoin Sodium Injection, USP.
GeneraMedix offers Fosphenytoin Sodium Injection, USP, 50 mg PE*/mL in
2 and 10 mL vials, preservative free.
Ronald F. Quadrel, President and CEO of GeneraMedix Inc. stated,
"Fosphenytoin represents our fifth generic injectable product launch in the
last two months. Our portfolio of product offerings continues to grow at a
very rapid pace. We are continuing to develop and file additional
Abbreviated New Drug Applications (ANDAs) for many other generic
injectables and expect to further expand and diversify our injectable
product line."
About GeneraMedix Inc.
GeneraMedix Inc. is a privately held pharmaceutical company offering
high quality generic injectable products to the U.S. hospital and specialty
markets. In addition to its products already marketed, GeneraMedix has a
significant number of injectable products under development, as well as a
number of products currently under FDA review. Headquartered in Liberty
Corner, New Jersey, the company was founded in July of 2004. Additional
information is available on the company's website at www.generamedix.com.
* PE = phenytoin sodium equivalent.
SOURCE GeneraMedix Inc.